Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.

Howes OD, Montgomery AJ, Asselin MC, Murray RM, Grasby PM, McGuire PK.

Br J Psychiatry Suppl. 2007 Dec;51:s13-8. doi: 10.1192/bjp.191.51.s13. Review.

2.

The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.

Howes OD, McCutcheon R, Owen MJ, Murray RM.

Biol Psychiatry. 2017 Jan 1;81(1):9-20. doi: 10.1016/j.biopsych.2016.07.014. Epub 2016 Aug 6. Review.

3.

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S.

Curr Pharm Des. 2009;15(22):2550-9. Review.

4.

The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Howes OD, Kapur S.

Schizophr Bull. 2009 May;35(3):549-62. doi: 10.1093/schbul/sbp006. Epub 2009 Mar 26. Review.

5.

The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episode.

Bonoldi I, Howes OD.

Adv Pharmacol. 2013;68:199-220. doi: 10.1016/B978-0-12-411512-5.00010-5. Review.

PMID:
24054146
6.

Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.

Bonoldi I, Howes OD.

CNS Drugs. 2014 Jul;28(7):649-63. doi: 10.1007/s40263-014-0177-z. Review.

PMID:
24919790
7.

Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies.

Kambeitz J, Abi-Dargham A, Kapur S, Howes OD.

Br J Psychiatry. 2014 Jun;204(6):420-9. doi: 10.1192/bjp.bp.113.132308. Review.

8.

[Brain imaging and transition to psychosis].

McGuire P.

Encephale. 2010 Mar;36 Suppl 3:S66-70. doi: 10.1016/S0013-7006(10)70033-6. Review. French.

PMID:
21095395
9.

Dopaminergic basis of salience dysregulation in psychosis.

Winton-Brown TT, Fusar-Poli P, Ungless MA, Howes OD.

Trends Neurosci. 2014 Feb;37(2):85-94. doi: 10.1016/j.tins.2013.11.003. Epub 2014 Jan 2. Review.

PMID:
24388426
10.

The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.

Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW.

Biol Psychiatry. 2011 Jun 15;69(12):e145-57. doi: 10.1016/j.biopsych.2011.02.036. Epub 2011 May 6. Review.

PMID:
21550021
11.

Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies.

Epstein J, Stern E, Silbersweig D.

Ann N Y Acad Sci. 1999 Jun 29;877:562-74. Review.

PMID:
10415671
12.

Dopaminergic function and progression of Parkinson's disease: PET findings.

Biju G, de la Fuente-Fernández R.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S38-40. doi: 10.1016/S1353-8020(09)70833-8. Review.

PMID:
20123555
13.

Mapping prodromal psychosis: a critical review of neuroimaging studies.

Fusar-Poli P, McGuire P, Borgwardt S.

Eur Psychiatry. 2012 Apr;27(3):181-91. doi: 10.1016/j.eurpsy.2011.06.006. Epub 2011 Sep 21. Review.

PMID:
21940151
15.

Positron emission tomography and the striatal dopaminergic terminals in monkeys and in man.

Aquilonius SM, Hartvig P, Långström B, Tedroff J.

Acta Radiol Suppl. 1991;376:50-2. Review. No abstract available.

PMID:
1666778
16.

In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

Nikolaus S, Antke C, Müller HW.

Behav Brain Res. 2009 Dec 1;204(1):32-66. doi: 10.1016/j.bbr.2009.06.009. Epub 2009 Jun 10. Review.

PMID:
19523495
17.
18.

D3 dopamine receptor, behavioral sensitization, and psychosis.

Richtand NM, Woods SC, Berger SP, Strakowski SM.

Neurosci Biobehav Rev. 2001 Jul;25(5):427-43. Review.

PMID:
11566480

Supplemental Content

Support Center